Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Standardizing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia

Open access
Leigh, Margaret W., Hazucha, Milan J., Chawla, Kunal K., Baker, Brock R., Shapiro, Adam J., Brown, David E., LaVange, Lisa M., Horton, Bethany J., Qaqish, Bahjat, Carson, Johnny L., Davis, Stephanie D., Dell, Sharon D., Ferkol, Thomas W., Atkinson, Jeffrey J., Olivier, Kenneth N., Sagel, Scott D., Rosenfeld, Margaret, Milla, Carlos, Lee, Hye-Seung, Krischer, Jeffrey, Zariwala, Maimoona A., Knowles, Michael R.·2013·Annals of the American Thoracic Society

Abstract

Rationale: Several studies suggest that nasal nitric oxide (nNO) measurement could be a test for primary ciliary dyskinesia (PCD), but the procedure and interpretation have not been standardized. Objectives: To use a standard protocol for measuring nNO to establish a disease-specific cutoff value at one site, and then validate at six other sites. Methods: At the lead site, nNO was prospectively measured in individuals later confirmed to have PCD by ciliary ultrastructural defects (n = 143) or DNAH11 mutations (n = 6); and in 78 healthy and 146 disease control subjects, including individuals with asthma (n = 37), cystic fibrosis (n = 77), and chronic obstructive pulmonary disease (n = 32). A disease-specific cutoff value was determined, using generalized estimating equations (GEEs). Six other sites prospectively measured nNO in 155 consecutive individuals enrolled for evaluation for possible PCD. Measurements and Main Results: At the lead site, nNO values in PCD (mean ± standard deviation, 20.7 ± 24.1 nl/min; range, 1.5–207.3 nl/min) only rarely overlapped with the nNO values of healthy control subjects (304.6 ± 118.8; 125.5–867.0 nl/min), asthma (267.8 ± 103.2; 125.0–589.7 nl/min), or chronic obstructive pulmonary disease (223.7 ± 87.1; 109.7–449.1 nl/min); however, there was overlap with cystic fibrosis (134.0 ± 73.5; 15.6–386.1 nl/min). The disease-specific nNO cutoff value was defined at 77 nl/minute (sensitivity, 0.98; specificity, >0.999). At six other sites, this cutoff identified 70 of the 71 (98.6%) participants with confirmed PCD. Conclusions: Using a standardized protocol in multicenter studies, nNO measurement accurately identifies individuals with PCD, and supports its usefulness as a test to support the clinical diagnosis of PCD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1513/annalsats.201305-110oc

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 273

Metadata

Authors
Leigh, M. W., Hazucha, M. J., Chawla, K. K., Baker, B. R., Shapiro, A. J., Brown, D. E., LaVange, L. M., Horton, B. J., Qaqish, B., Carson, J. L., Davis, S. D., Dell, S. D., Ferkol, T. W., Atkinson, J. J., Olivier, K. N., Sagel, S. D., Rosenfeld, M., Milla, C., Lee, H.-S., Krischer, J., Zariwala, M. A., & Knowles, M. R.
Venue
Annals of the American Thoracic Society
Published
2013-12-01
Volume
10
Issue
6
Pages
574-581
ISSN
  • 2325-6621 (ISSN-L)
  • 2329-6933
OpenAlex
W1965779264
Cited by
273
References
32
FWCI
18.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standardizing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia. https://app.cochat.ai/papers/10.1513/annalsats.201305-110oc
The paper
Leigh, M. W., Hazucha, M. J., Chawla, K. K., Baker, B. R., Shapiro, A. J., Brown, D. E., LaVange, L. M., Horton, B. J., Qaqish, B., Carson, J. L., Davis, S. D., Dell, S. D., Ferkol, T. W., Atkinson, J. J., Olivier, K. N., Sagel, S. D., Rosenfeld, M., Milla, C., Lee, H.-S., . . . Knowles, M. R. (2013). Standardizing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia. Annals of the American Thoracic Society. https://doi.org/10.1513/annalsats.201305-110oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.